Company: IXHL
Filing Date: 2025-04-28
Form Type: 424B3
Source: 0001213900-25-036065
Chunk: 13

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: 424B3
Chunk 13
---
 day after the Release Date. Additionally, we may not issue more than seven shares of Common Stock pursuant
to the Sales Agreement prior to the date of the Stockholder Approval as we currently have no other authorized shares of Common Stock available
for issuance pursuant to the Sales Agreement. As a result, we will likely be unable to utilize the Sales Agreement in the near term.

Implications of Being an Emerging Growth Company and Smaller Reporting Company

We are an “emerging
growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). We may take advantage
of certain exemptions from various public company reporting requirements, including not being required to have our internal control over
financial reporting audited by our independent registered public accounting firm under Section 404 of the Sarbanes-Oxley Act of 2002 (the
“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments.
We may take advantage of these exemptions until the last day of our fiscal year following the fifth anniversary of the date of the first
sale of our common equity securities pursuant to an effective registration statement under the Securities Act or until we are no longer
an “emerging growth company,” whichever is earlier. We will cease to be an emerging growth company prior to the end of such
period if certain earlier events occur, including if we become a “large accelerated filer” as defined in Rule 12b-2 under
the Exchange Act, our annual gross revenues exceed $1.235 billion or we issue more than $1.0 billion of non-convertible debt in any three-year
period.

Under the JOBS Act, emerging
growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies.
We have elected to use this extended transition period under the JOBS Act until the earlier of the date we (i) are no longer an emerging
growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act.

We are also a “smaller
reporting company” as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer
an emerging growth company, which would allow us to take advantage of many of the same exemptions available to emerging growth companies,
including not